Africa Leads New TB Vaccine Trial That Could Save Millions

Scientists in South Africa are leading a breakthrough tuberculosis vaccine trial that could protect adolescents and adults for the first time in over a century.

The M72 vaccine, combined with faster tests and shorter treatments, marks a turning point against the world's deadliest infectious disease.